Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced that it has entered into an exclusive option agreement to acquire Provista Diagnostics, Inc., an in vitro diagnostics company with a CLIA/CAP certified lab in Alpharetta, Georgia, developing and commercializing the proprietary Videssa® blood test for breast cancer. Videssa has been clinically validated for the early and accurate detection of breast cancer based on data from over one thousand patient samples.
Read the full article: Todos Medical Enters into Exclusive Option Agreement to Acquire Provista Diagnostics //
Source: https://www.globenewswire.com/news-release/2020/01/09/1968392/0/en/Todos-Medical-Enters-into-Exclusive-Option-Agreement-to-Acquire-Provista-Diagnostics-and-Announces-Management-Changes.html